Sema4 Holdings Corp. (NASDAQ: SMFR) Stock Competitors & Peer Comparison

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, GEHC has a market cap of 32.4B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while GEHC trades at $71.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas GEHC's P/E ratio is 15.74. In terms of profitability, SMFR's ROE is -0.39%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, SMFR is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check GEHC's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while GEHCV trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas GEHCV's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, SMFR is more volatile compared to GEHCV. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check GEHCV's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, BTSG has a market cap of 12.3B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while BTSG trades at $62.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas BTSG's P/E ratio is 50.35. In terms of profitability, SMFR's ROE is -0.39%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, SMFR is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check BTSG's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, TEM has a market cap of 9.1B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while TEM trades at $52.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas TEM's P/E ratio is -104.10. In terms of profitability, SMFR's ROE is -0.39%, compared to TEM's ROE of -0.55%. Regarding short-term risk, SMFR is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check TEM's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while SGFY trades at $30.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas SGFY's P/E ratio is 70.91. In terms of profitability, SMFR's ROE is -0.39%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, SMFR is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check SGFY's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, HQY has a market cap of 8.7B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while HQY trades at $104.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas HQY's P/E ratio is 24.45. In terms of profitability, SMFR's ROE is -0.39%, compared to HQY's ROE of +0.11%. Regarding short-term risk, SMFR is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check HQY's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, HNGE has a market cap of 6.9B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while HNGE trades at $89.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas HNGE's P/E ratio is 47.81. In terms of profitability, SMFR's ROE is -0.39%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, SMFR is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check HNGE's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, TXG has a market cap of 6.6B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while TXG trades at $52.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas TXG's P/E ratio is -306.06. In terms of profitability, SMFR's ROE is -0.39%, compared to TXG's ROE of -0.09%. Regarding short-term risk, SMFR is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check TXG's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while RCM trades at $14.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas RCM's P/E ratio is -102.21. In terms of profitability, SMFR's ROE is -0.39%, compared to RCM's ROE of +0.00%. Regarding short-term risk, SMFR is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check RCM's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, DOCS has a market cap of 5.1B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while DOCS trades at $27.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas DOCS's P/E ratio is 17.91. In terms of profitability, SMFR's ROE is -0.39%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, SMFR is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for SMFR.Check DOCS's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, WAY has a market cap of 4.6B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while WAY trades at $24.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas WAY's P/E ratio is 16.05. In terms of profitability, SMFR's ROE is -0.39%, compared to WAY's ROE of +0.04%. Regarding short-term risk, SMFR is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check WAY's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while ONEM trades at $16.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas ONEM's P/E ratio is -7.77. In terms of profitability, SMFR's ROE is -0.39%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, SMFR is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check ONEM's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, PRVA has a market cap of 2.8B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while PRVA trades at $22.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas PRVA's P/E ratio is 106.90. In terms of profitability, SMFR's ROE is -0.39%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, SMFR is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check PRVA's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, HTFL has a market cap of 2.5B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while HTFL trades at $28.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas HTFL's P/E ratio is -14.34. In terms of profitability, SMFR's ROE is -0.39%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, SMFR is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check HTFL's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, WGS has a market cap of 2.3B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while WGS trades at $77.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas WGS's P/E ratio is 214.11. In terms of profitability, SMFR's ROE is -0.39%, compared to WGS's ROE of -0.39%. Regarding short-term risk, SMFR is more volatile compared to WGS. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check WGS's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, PGNY has a market cap of 2.2B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while PGNY trades at $28.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas PGNY's P/E ratio is 20.36. In terms of profitability, SMFR's ROE is -0.39%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, SMFR is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check PGNY's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, WGSWW has a market cap of 1.8B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while WGSWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas WGSWW's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, SMFR is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check WGSWW's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while NXGN trades at $23.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas NXGN's P/E ratio is -266.00. In terms of profitability, SMFR's ROE is -0.39%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, SMFR is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check NXGN's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while OMDA trades at $23.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas OMDA's P/E ratio is 338.14. In terms of profitability, SMFR's ROE is -0.39%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, SMFR is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check OMDA's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while AGTI trades at $10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas AGTI's P/E ratio is -71.79. In terms of profitability, SMFR's ROE is -0.39%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, SMFR is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check AGTI's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, TDOC has a market cap of 1.3B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while TDOC trades at $7.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas TDOC's P/E ratio is -7.92. In terms of profitability, SMFR's ROE is -0.39%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, SMFR is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check TDOC's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while CERT trades at $8.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas CERT's P/E ratio is 20.50. In terms of profitability, SMFR's ROE is -0.39%, compared to CERT's ROE of -0.07%. Regarding short-term risk, SMFR is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check CERT's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, GDRX has a market cap of 1.3B. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while GDRX trades at $3.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas GDRX's P/E ratio is 11.50. In terms of profitability, SMFR's ROE is -0.39%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, SMFR is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check GDRX's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while CCLDO trades at $27.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas CCLDO's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, SMFR is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check CCLDO's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, HSTM has a market cap of 839.1M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while HSTM trades at $28.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas HSTM's P/E ratio is 35.46. In terms of profitability, SMFR's ROE is -0.39%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, SMFR is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check HSTM's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, PHR has a market cap of 773M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while PHR trades at $12.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas PHR's P/E ratio is 44.66. In terms of profitability, SMFR's ROE is -0.39%, compared to PHR's ROE of +0.03%. Regarding short-term risk, SMFR is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check PHR's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while MPLN-WT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, SMFR is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for SMFR.Check MPLN-WT's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while ACCD trades at $7.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas ACCD's P/E ratio is -3.08. In terms of profitability, SMFR's ROE is -0.39%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, SMFR is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check ACCD's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, CTEV has a market cap of 546.7M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while CTEV trades at $32.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas CTEV's P/E ratio is -2.46. In terms of profitability, SMFR's ROE is -0.39%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, SMFR is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for SMFR.Check CTEV's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, SOPH has a market cap of 537.5M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while SOPH trades at $7.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas SOPH's P/E ratio is -6.95. In terms of profitability, SMFR's ROE is -0.39%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, SMFR is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check SOPH's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while SHCR trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas SHCR's P/E ratio is -3.76. In terms of profitability, SMFR's ROE is -0.39%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, SMFR is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check SHCR's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, NRC has a market cap of 458.4M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while NRC trades at $20.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas NRC's P/E ratio is 24.80. In terms of profitability, SMFR's ROE is -0.39%, compared to NRC's ROE of +0.48%. Regarding short-term risk, SMFR is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check NRC's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, EVH has a market cap of 446M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while EVH trades at $3.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas EVH's P/E ratio is 30.50. In terms of profitability, SMFR's ROE is -0.39%, compared to EVH's ROE of -0.99%. Regarding short-term risk, SMFR is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check EVH's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while SLGCW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, SMFR's ROE is -0.39%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, SMFR is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for SMFR.Check SLGCW's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while SLGC trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas SLGC's P/E ratio is -3.04. In terms of profitability, SMFR's ROE is -0.39%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, SMFR is more volatile compared to SLGC. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check SLGC's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while TBRG trades at $26.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas TBRG's P/E ratio is 9.37. In terms of profitability, SMFR's ROE is -0.39%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, SMFR is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check TBRG's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while MPLN trades at $23.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas MPLN's P/E ratio is -0.23. In terms of profitability, SMFR's ROE is -0.39%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, SMFR is more volatile compared to MPLN. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check MPLN's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, SY has a market cap of 286M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while SY trades at $2.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas SY's P/E ratio is -6.61. In terms of profitability, SMFR's ROE is -0.39%, compared to SY's ROE of -0.16%. Regarding short-term risk, SMFR is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check SY's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while TRHC trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas TRHC's P/E ratio is -4.27. In terms of profitability, SMFR's ROE is -0.39%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, SMFR is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check TRHC's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, SPOK has a market cap of 240.6M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while SPOK trades at $11.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas SPOK's P/E ratio is 19.20. In terms of profitability, SMFR's ROE is -0.39%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, SMFR is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check SPOK's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, AMWL has a market cap of 228.6M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while AMWL trades at $13.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas AMWL's P/E ratio is -3.04. In terms of profitability, SMFR's ROE is -0.39%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, SMFR is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check AMWL's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while CPSI trades at $9.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas CPSI's P/E ratio is -183.80. In terms of profitability, SMFR's ROE is -0.39%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, SMFR is more volatile compared to CPSI. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check CPSI's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, OPRX has a market cap of 132.9M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while OPRX trades at $7.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas OPRX's P/E ratio is 6.50. In terms of profitability, SMFR's ROE is -0.39%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, SMFR is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check OPRX's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, HCAT has a market cap of 127.8M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while HCAT trades at $1.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas HCAT's P/E ratio is 8.65. In terms of profitability, SMFR's ROE is -0.39%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, SMFR is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check HCAT's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while AUGX trades at $2.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas AUGX's P/E ratio is -4.99. In terms of profitability, SMFR's ROE is -0.39%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, SMFR is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check AUGX's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, CCLD has a market cap of 111.8M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while CCLD trades at $2.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas CCLD's P/E ratio is 10.12. In terms of profitability, SMFR's ROE is -0.39%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, SMFR is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check CCLD's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, DH has a market cap of 75.3M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while DH trades at $0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas DH's P/E ratio is 2.74. In terms of profitability, SMFR's ROE is -0.39%, compared to DH's ROE of -0.67%. Regarding short-term risk, SMFR is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check DH's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, WORX has a market cap of 72.8M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while WORX trades at $4.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas WORX's P/E ratio is -5.29. In terms of profitability, SMFR's ROE is -0.39%, compared to WORX's ROE of -0.65%. Regarding short-term risk, SMFR is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for SMFR.Check WORX's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while FORA trades at $2.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas FORA's P/E ratio is -24.11. In terms of profitability, SMFR's ROE is -0.39%, compared to FORA's ROE of -0.17%. Regarding short-term risk, SMFR is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check FORA's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while CCLDP trades at $19.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas CCLDP's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, SMFR is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check CCLDP's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, ONMDW has a market cap of 37M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while ONMDW trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas ONMDW's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, SMFR is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check ONMDW's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, ONMD has a market cap of 35.6M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while ONMD trades at $0.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas ONMD's P/E ratio is -4.16. In terms of profitability, SMFR's ROE is -0.39%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, SMFR is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check ONMD's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while SNCE trades at $5.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas SNCE's P/E ratio is -0.27. In terms of profitability, SMFR's ROE is -0.39%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, SMFR is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check SNCE's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while AKLI trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas AKLI's P/E ratio is -0.71. In terms of profitability, SMFR's ROE is -0.39%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, SMFR is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check AKLI's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while SHLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas SHLT's P/E ratio is -3.87. In terms of profitability, SMFR's ROE is -0.39%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, SMFR is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check SHLT's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while SHCRW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, SMFR's ROE is -0.39%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, SMFR is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check SHCRW's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while STRM trades at $5.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas STRM's P/E ratio is -2.40. In terms of profitability, SMFR's ROE is -0.39%, compared to STRM's ROE of -0.65%. Regarding short-term risk, SMFR is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check STRM's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while RNLX trades at $0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas RNLX's P/E ratio is -0.33. In terms of profitability, SMFR's ROE is -0.39%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, SMFR is more volatile compared to RNLX. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check RNLX's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while LIFW trades at $3.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas LIFW's P/E ratio is -0.02. In terms of profitability, SMFR's ROE is -0.39%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, SMFR is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check LIFW's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while BBLN trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas BBLN's P/E ratio is -0.04. In terms of profitability, SMFR's ROE is -0.39%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, SMFR is more volatile compared to BBLN. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check BBLN's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, BEATW has a market cap of 11.7M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while BEATW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas BEATW's P/E ratio is -0.03. In terms of profitability, SMFR's ROE is -0.39%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, SMFR is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check BEATW's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while ETAO trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas ETAO's P/E ratio is -0.01. In terms of profitability, SMFR's ROE is -0.39%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, SMFR is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for SMFR.Check ETAO's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, MGRX has a market cap of 8.3M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while MGRX trades at $0.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas MGRX's P/E ratio is -0.36. In terms of profitability, SMFR's ROE is -0.39%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, SMFR is more volatile compared to MGRX. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check MGRX's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, BFRG has a market cap of 6.9M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while BFRG trades at $0.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas BFRG's P/E ratio is -1.09. In terms of profitability, SMFR's ROE is -0.39%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, SMFR is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check BFRG's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, SCNX has a market cap of 5.9M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while SCNX trades at $0.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas SCNX's P/E ratio is -0.15. In terms of profitability, SMFR's ROE is -0.39%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, SMFR is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check SCNX's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while UPH trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas UPH's P/E ratio is -0.07. In terms of profitability, SMFR's ROE is -0.39%, compared to UPH's ROE of -1.05%. Regarding short-term risk, SMFR is more volatile compared to UPH. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check UPH's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while UPH-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, SMFR is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for SMFR.Check UPH-WT's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while PEARW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas PEARW's P/E ratio is -0.00. In terms of profitability, SMFR's ROE is -0.39%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, SMFR is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for SMFR.Check PEARW's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while PEAR trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas PEAR's P/E ratio is -0.08. In terms of profitability, SMFR's ROE is -0.39%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, SMFR is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for SMFR.Check PEAR's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while OTRK trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas OTRK's P/E ratio is -0.02. In terms of profitability, SMFR's ROE is -0.39%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, SMFR is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check OTRK's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while CMAX trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas CMAX's P/E ratio is -0.00. In terms of profitability, SMFR's ROE is -0.39%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, SMFR is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check CMAX's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, HCTI has a market cap of 1.4M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while HCTI trades at $1.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas HCTI's P/E ratio is -0.16. In terms of profitability, SMFR's ROE is -0.39%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, SMFR is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check HCTI's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, VSEEW has a market cap of 1.4M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while VSEEW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, SMFR's ROE is -0.39%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, SMFR is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for SMFR.Check VSEEW's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while LIFWZ trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, SMFR is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check LIFWZ's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, ACON has a market cap of 1.2M. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while ACON trades at $2.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas ACON's P/E ratio is -0.25. In terms of profitability, SMFR's ROE is -0.39%, compared to ACON's ROE of -0.59%. Regarding short-term risk, SMFR is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check ACON's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, EUDAW has a market cap of 952.7K. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while EUDAW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, SMFR's ROE is -0.39%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, SMFR is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check EUDAW's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, VSEE has a market cap of 816.5K. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while VSEE trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas VSEE's P/E ratio is -0.10. In terms of profitability, SMFR's ROE is -0.39%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, SMFR is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for SMFR.Check VSEE's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while MSPRZ trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, SMFR is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for SMFR.Check MSPRZ's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while KERN trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas KERN's P/E ratio is -0.01. In terms of profitability, SMFR's ROE is -0.39%, compared to KERN's ROE of -0.20%. Regarding short-term risk, SMFR is more volatile compared to KERN. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check KERN's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while KERNW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas KERNW's P/E ratio is -0.00. In terms of profitability, SMFR's ROE is -0.39%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, SMFR is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for SMFR.Check KERNW's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while LIFWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas LIFWW's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, SMFR is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check LIFWW's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, ZCMD has a market cap of 37.5K. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while ZCMD trades at $1.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas ZCMD's P/E ratio is -0.04. In terms of profitability, SMFR's ROE is -0.39%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, SMFR is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check ZCMD's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while CMAXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas CMAXW's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, SMFR is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check CMAXW's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, ACONW has a market cap of 13.2K. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while ACONW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas ACONW's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, SMFR is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check ACONW's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while CHNG trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas CHNG's P/E ratio is -152.72. In terms of profitability, SMFR's ROE is -0.39%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, SMFR is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check CHNG's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while MTBC trades at $3.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas MTBC's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, SMFR is more volatile compared to MTBC. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check MTBC's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while KURIU trades at $9.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas KURIU's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, SMFR is more volatile compared to KURIU. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check KURIU's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while CNVY trades at $10.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas CNVY's P/E ratio is -71.50. In terms of profitability, SMFR's ROE is -0.39%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, SMFR is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check CNVY's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while MTBCP trades at $26.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas MTBCP's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, SMFR is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check MTBCP's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while MSPRV trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas MSPRV's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to MSPRV's ROE of N/A. Regarding short-term risk, SMFR is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for SMFR.Check MSPRV's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while SMFRW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas SMFRW's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, SMFR is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for SMFR.Check SMFRW's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, IMS has a market cap of 0. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while IMS trades at $31.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas IMS's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to IMS's ROE of +0.27%. Regarding short-term risk, SMFR is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check IMS's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while NAVA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas NAVA's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, SMFR is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for SMFR.Check NAVA's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while AFFX trades at $14.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas AFFX's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, SMFR is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check AFFX's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while CHNGU trades at $73.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas CHNGU's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, SMFR is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check CHNGU's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, NH has a market cap of 0. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while NH trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas NH's P/E ratio is -0.12. In terms of profitability, SMFR's ROE is -0.39%, compared to NH's ROE of +0.35%. Regarding short-term risk, SMFR is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for SMFR.Check NH's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while CSLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas CSLT's P/E ratio is -37.27. In terms of profitability, SMFR's ROE is -0.39%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, SMFR is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check CSLT's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, CERN has a market cap of 0. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while CERN trades at $94.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas CERN's P/E ratio is 55.84. In terms of profitability, SMFR's ROE is -0.39%, compared to CERN's ROE of +0.14%. Regarding short-term risk, SMFR is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check CERN's competition here

Sema4 Holdings Corp. (NASDAQ: SMFR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMFR stands at 246.4M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, SMFR is priced at $0.31 on the NASDAQ, while MTBCO trades at $25.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMFR currently has a P/E ratio of N/A, whereas MTBCO's P/E ratio is N/A. In terms of profitability, SMFR's ROE is -0.39%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, SMFR is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for SMFR.Check MTBCO's competition here